How big is the Middle East And Africa Biguanide Market?

The Middle East And Africa Biguanide Market size is expected to reach USD 311.96 million in 2024 and grow at a CAGR of 3.52% to reach USD 370.86 million by 2029. Read More

What is the current Middle East And Africa Biguanide Market size?

In 2024, the Middle East And Africa Biguanide Market size is expected to reach USD 311.96 million. Read More

Who are the key players in Middle East And Africa Biguanide Market?

Bristol Myers Squibb, Teva, Sanofi Aventis, Merck and Co. and Glenmark Pharmaceuticals are the major companies operating in the Middle East And Africa Biguanide Market. Read More

What years does this Middle East And Africa Biguanide Market cover, and what was the market size in 2023?

In 2023, the Middle East And Africa Biguanide Market size was estimated at USD 300.98 million. The report covers the Middle East And Africa Biguanide Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Middle East And Africa Biguanide Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Middle East And Africa Biguanide Market Share

Statistics for the 2023 & 2024 Middle East And Africa Biguanide market share, created by Mordor Intelligence™ Industry Reports. Middle East And Africa Biguanide share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Middle East And Africa Biguanide Industry

The Middle East and African biguanide market is fragmented, with manufacturers like Takeda, Merck, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, and Boehringer Ingelheim Pharmaceuticals, etc. having a global market presence and other regional players.